Quantification of the effects of chlorpromazine on performance under delayed matching to sample in pigeons.
Chlorpromazine makes pigeons forget faster, showing that antipsychotics can target memory without slowing movement.
01Research in Context
What this study did
Zigler et al. (1989) gave pigeons a memory game. The birds had to peck a key that matched a sample they saw seconds earlier.
The team injected chlorpromazine before some sessions. Doses ranged from 0.5 to 12.5 mg/kg. They watched how the drug changed accuracy and speed.
What they found
Chlorpromazine hurt memory in two ways. Birds forgot faster and mixed up the samples more often.
Yet the drug did not slow their pecking. The problem was memory, not motor skill.
How this fits with other research
WEINELong (1963) saw the same drug help pigeons. It restored food pecking that amphetamine had shut down. The tasks differ: simple fixed-ratio work versus memory. The drug hurts memory but can steady over-aroused birds.
Martens et al. (1989) gave diazepam to humans learning new button sequences. Like chlorpromazine, the drug harmed new learning more than old. Both papers show that calming drugs hit acquisition hardest.
Goldman et al. (1979) found the same pattern with stimulants in monkeys. Acquisition dropped while old chains stayed intact. Across species and drug classes, new learning is the fragile part.
Why it matters
If a client starts an antipsychotic, expect new skills to take longer. Break tasks into tiny steps and give extra practice trials. Keep the old routines running—they are safer from drug effects.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add five extra acquisition trials when a client begins any antipsychotic.
02At a glance
03Original abstract
The effects of four doses of chlorpromazine (dose range 0.5 to 12.5 mg/kg) on performance under a delayed matching-to-sample procedure in pigeons was investigated, using the exponential model of memory (White, 1985). Performance was measured using a bias-free measure of discriminability, log d (Davison & Tustin, 1978), and negative exponential functions were fitted to individual-subject and group data at each dose level. A decrease in matching accuracy was found to be caused by an increase in the rate of forgetting, b, and a decrease in the initial discriminability, log d0. Changes in rate of forgetting and discriminability occurred at doses that had no statistically significant effect on response latency. The exponential model of memory accounted well for the data and provided a useful way of quantifying the effects of chlorpromazine on the processes involved in delayed matching-to-sample performance.
Journal of the experimental analysis of behavior, 1989 · doi:10.1901/jeab.1989.51-317